Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AIM WINNERS & LOSERS: Sosandar rises; Boots buys MyHealthChecked unit

14th Oct 2025 10:33

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

----------

AIM - WINNERS

----------

Sosandar PLC, up 3.8% at 5.45 pence, 12-month range 4.50p-11.42p. The fashion firm says it has returned to revenue growth and is trading in line with market expectations. For the half-year to September, it expects to report a revenue increase of 15% to GBP18.7 million from GBP16.2 million, though a widened pretax loss of GBP1.1 million from GBP700,000. The loss is in line with expectations and represents the usual "second half weighting" of profit and the hit from a cyber incident at Marks & Spencer Group PLC. Sosandar products are available through the M&S online offering. Sosandar says it is trading in line with expectations for annual revenue and pretax profit. It puts market expectations at GBP43.6 million for revenue and GBP400,000 for pretax profit. For the year ended March, Sosandar had reported revenue of GBP37.1 million and a pretax loss of GBP67,00.

----------

Fevertree Drinks PLC, up 5.3% at 828.57p, 12-month range 608.50p-1,020.00p. Jefferies raises the mixers maker to 'buy' from 'hold'. It increases its price target to 1,100p from 900p.

----------

AIM - LOSERS

----------

MyHealthChecked PLC, down 22% at 7.80p, 12-month range 6.12p-21.00p. Shares hit this 12-month low on Tuesday as the home-testing healthcare products firm strikes a deal to sell its trading subsidiary Concepta Diagnostics Ltd to retailer Boots UK Ltd for GBP2.4 million. MyHealthChecked will be a cash shell when the deal concludes. "Concepta distributes and commercialises a range of at-home healthcare and wellness tests and has developed an accompanying proprietary digital platform. The Company has worked closely with Boots to develop its wellness portfolio and digital offering since its launch in May 2023 and has developed the platform to meet Boots' requirements since the relationship began in May 2021," MyHealthChecked says. MyHealthChecked believes Concepta is likely to be loss-making for the foreseeable future so a sale is in the best interests of shareholders. Shareholders will vote on the disposal at a general meeting on November 4.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to [email protected]

Copyright 2025 Alliance News Ltd. All Rights Reserved.


Related Shares:

FevertreeMyhlth ChckSosandarMarks & Spencer
FTSE 100 Latest
Value9,714.96
Change13.59